Stachyose, a prebiotic oligosaccharide found in various plants, is gaining attention for its potential to ease inflammatory bowel diseases like ulcerative colitis (UC). A new mouse study sheds light on how stachyose might help manage colitis, focusing especially on its effects on gut inflammation, beneficial microbes, and key fatty acids in the colon.
What Did the Researchers Do?
Researchers used a well-established mouse model in which colitis is induced using dextran sulfate sodium (DSS) to mimic symptoms seen in human UC. Mice were divided into three groups:
- A healthy control group
- A group exposed to DSS to induce colitis
- A group treated with stachyose (STA) plus DSS
Stachyose was administered orally for three weeks, with DSS added during the last week to trigger colitis. The scientists then looked at body weight, colon structure, inflammation markers, and changes in the gut microbiome and metabolites.
Key Findings: Stachyose Reduces Colitis Symptoms
Mice exposed to DSS suffered significant weight loss, colon shortening, increased disease activity, and more severe tissue damage. In contrast, the group that received stachyose showed the following improvements:
- Less weight loss and milder disease activity
- Reduced inflammatory infiltration and preservation of colon tissue structure
- A partial restoration of mucosal integrity, as seen in tissue samples
These findings suggest that stachyose can directly protect against and reverse colitis symptoms in this mouse model.
How Does Stachyose Work? Insights from Multi-Omics
To understand how stachyose works, researchers performed metabolomic and genetic analyses:
- Stachyose treatment led to higher levels of medium-chain fatty acids (MCFAs) in the colon, including beneficial compounds like azelaic acid and 3-hydroxyoctanoic acid.
- These MCFAs were strongly linked to better inflammation scores and healthier colon tissue.
- Mice receiving stachyose had higher levels of anti-inflammatory cytokines, especially IL-10, suggesting a more balanced immune environment.
On the genetic level, stachyose triggered increased activity in genes responsible for fatty acid metabolism and the PPAR signaling pathway, which together help reduce inflammation and support tissue repair.
Stachyose Modifies the Gut Microbiome
Another major benefit of stachyose was its positive effect on gut bacteria:
- DSS-induced colitis usually causes a loss in gut bacterial richness and diversity—a marker of dysbiosis and poor gut health.
- Stachyose partially restored microbial diversity, and the gut community in these mice started to resemble that of healthy controls again.
- Importantly, stachyose boosted populations of beneficial bacteria that make short-chain fatty acids (SCFAs) and other metabolites known for anti-inflammatory effects.
- Harmful bacteria associated with inflammation decreased in the stachyose group.
Why This Matters for Gut Health
This study strengthens the evidence that prebiotics like stachyose can help manage colitis, not just by supporting good bacteria but by altering the gut’s metabolic environment:
- Stachyose specifically increases colonic MCFAs, which are closely tied to reduced inflammation and better gut barrier function.
- The combined metabolic, genetic, and microbiome changes triggered by stachyose suggest it may offer a multi-faceted approach to managing colitis and protecting gut health.
Bottom Line
Stachyose supplementation in mice lessened inflammatory bowel symptoms, promoted anti-inflammatory compounds, and restored gut microbial balance. These findings pave the way for considering stachyose as a potential prebiotic supplement for colitis and possibly other gut health issues—but more studies in humans are needed before clinical recommendations can be made
